埃尔巴斯维尔在食道状细胞癌中通过NCOA4介导的ferritinophagy触发铁
Maoju Tang1,2, Feng Gong3, Miyuan Yang4
1Department of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, China.
Medical oncology (Northwood, London, England)
|February 21, 2026
概括
作为NS5A抑制剂的埃尔巴斯维尔通过向NCOA4和FTH1.1,有效地诱导食道状细胞癌 (ESCC) 的铁亡. 这种重新定位的策略显示出治疗耐治疗ESCC和其他依赖铁代谢的癌症的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物重用 药物重用
背景情况:
- 食道状细胞癌 (ESCC) 呈现出显著的治疗耐药性.
- 铁亡,一种受调节的细胞死亡途径,与癌症治疗有关.
- NS5A抑制剂主要以抗病毒活性而闻名.
研究的目的:
- 调查NS5A抑制剂Elbasvir作为ESCC治疗中潜在的铁灭诱导剂.
- 为了阐明埃尔巴斯维尔诱导的铁灭的分子机制.
- 在ESCC模型中评估Elbasvir的体内疗效和安全性.
主要方法:
- 细胞活力测试 (CCK-8),细胞流量计用于细胞亡和细胞周期分析.
- 对于关键蛋白质标记物来说,西式涂抹,对于蛋白质学来说,质谱学.
- 在BALB/c裸体小鼠体内异种移植研究,传输电子显微镜 (TEM).
- 铁化试验 (JC-1,FerroOrange,DCFH-DA,MDA),SPR和DARTS用于目标结合.
主要成果:
- 埃尔巴斯维尔 (40微米,48小时) 降低了ESCC细胞活力,并抑制了异种移植的生长,没有观察到毒性.
- 埃尔巴斯维尔诱导了细胞亡和G0/G1细胞周期的停止.
- 蛋白质学确定铁化是主要受影响的途径;埃尔巴斯维尔触发了NCOA4介导的铁代谢,FTH1降解,铁积累和脂质过氧化.
- 表面等离子体共振 (SPR) 和药物亲和度响应目标稳定性 (DARTS) 试验证实埃尔巴斯维尔与NCOA4结合.
结论:
- 埃尔巴斯维尔通过向NCOA4-FTH1复合体,有效地诱导ESCC中的铁亡,从而导致费里丁和细胞死亡.
- 埃尔巴斯维尔代表了治疗耐药ESCC的有前途的重用治疗策略.
- 良好的安全性概况表明,在依赖铁代谢的癌症中,临床转化有可能发生.
相关概念视频
01:16Necrosis
6.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.8K
01:28The Early Endosome: Endocytosis of Transferrin
4.9K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.9K
01:21Barrett Esophagus-II: Clinical Manifestations and Management
1.2K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.2K
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
818
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
818